Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study

Table 1 Characteristics of the study population at the start of combination antiretroviral therapy from 2003 to 2012 in British Columbia

Covariates and outcomes	Frequency (%) or
Covariates and outcomes	Median (Q₁ - Q₃)
Gender
Male	2979 (82 %)
Female	674 (18 %)
cART era
2003 - 2007	1554 (43 %)
2008 - 2012	2099 (57 %)
Age (years)
20 - 24	109 (3 %)
25 - 44	2138 (59 %)
45 - 64	1324 (36 %)
65 +	82 (2 %)
CD4 cell count (cells/mm³)
<50	421 (12 %)
50 - 199	1154 (32 %)
200 - 349	1172 (32 %)
350+	906 (25 %)
Viral load (log₁₀copies/mL)
<5.00	1545 (42 %)
5.00+	2108 (58 %)
Adherence to therapy during the first year on cART (%)
≥95 %	2464 (67 %)
80 - <95 %	501 (14 %)
40 - <80 %	468 (13 %)
0 - <40 %	220 (6 %)
Follow-up (person-years)	4.50 (2.40 - 6.80)

cART combination antiretroviral therapy; Q₁ stands for 25^th percentile; Q₃ stands for 75^th percentile

ISSN: 1472-6963